Maternal blood tests reduce false positives in prenatal screening, study finds

02/27/2014 | NBC News

Prenatal screenings that analyze small amounts of fetal DNA found in maternal blood samples may be more accurate at detecting congenital defects than conventional methods, according to a study in the New England Journal of Medicine. In test results for 2,000 pregnancies, cell-free DNA tests produced false positives at a rate 10 times lower than that of standard screening measures performed later in pregnancy.

View Full Article in:

NBC News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
Springfield, OR
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA